Atlas Trials

A Study in Schizophrenia Patients

Clinical trial NCT01086748 · COMPLETED

Trial details

NCT number
NCT01086748
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2010-03-01
Primary completion
2012-05-01
Enrollment
880

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.